ConductScience.org, home

Paper5000267

Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.

Marks MI and 1 other. Antimicrob Agents Chemother (Bethesda), 1970. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Papers, record 5000267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5000267

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.
PubMed
Journal
Antimicrob Agents Chemother (Bethesda)
PubMed
Year
1970
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.48
iCite
Revised in PubMed
2025-10-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marks MIM I
2Eickhoff TCT C

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
CytosineMajor topic
FluorineMajor topic
YeastsMajor topic
Antibody Formation
Candida
Cryptococcus
Evaluation Studies as Topic
Hemolytic Plaque Technique
Immunodiffusion
Indicator Dilution Techniques
Methods
Microbial Sensitivity Tests
Saccharomyces

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
6753737Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6753737PubMed
5165106In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).Appl Microbiol1971https://conductscience.org/library/papers/5165106PubMed
4742920Pediatric antimicrobial therapy. VI.Can Med Assoc J1973https://conductscience.org/library/papers/4742920PubMed
4598611Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4598611PubMed
3988896Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing.J Clin Microbiol1985https://conductscience.org/library/papers/3988896PubMed
464576Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/464576PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5000267

GET https://conductscience.org/api/papers/v1/5000267/authors